Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Malignant atrophic papulosis.

R Degos

    The British Journal of Dermatology
    |January 1, 1979
    PubMed
    Summary
    This summary is machine-generated.

    Malignant atrophic papulosis (MAP) is a rare syndrome with a characteristic skin rash but severe internal lesions. Early diagnosis is crucial due to its serious prognosis and limited treatment options.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    [R. Degos, E. Rivalier, P. Lefort: "Griseofulvin". 1960].

    Annales de dermatologie et de venereologie·2001
    Same author

    [Darier's atypical tuberculous ulcer].

    Annales de dermatologie et de venereologie·1983
    Same author

    [Silvery hair in children: a symptom of leucogranulocytic and melanocytic diseases (author's transl)].

    Annales de dermatologie et de venereologie·1981
    Same author

    [Pemphigus with clinical aspect of Darier's erythema annular centrifugum and histological picture of eosinophilic spongiosis].

    Annales de dermatologie et de venereologie·1978
    Same author

    [Idiopathic eruptive macular pigmentation (author's transl)].

    Annales de dermatologie et de venereologie·1978
    Same author

    [Acrokerato-elastoidosis].

    Annales de dermatologie et de venereologie·1977
    Same journal

    Comment on 'Incidence and Mortality of Mucous Membrane Pemphigoid in France': reply from authors.

    The British journal of dermatology·2026
    Same journal

    Randomised Controlled Feasibility Trial of an Intervention to Reduce Infant Bathing.

    The British journal of dermatology·2026
    Same journal

    Dupilumab treatment restores skin nerve fibre density in patients with moderate-to-severe atopic dermatitis: results from DIFFERENSTAD, an open-label exploratory study.

    The British journal of dermatology·2026
    Same journal

    Mee's Lines.

    The British journal of dermatology·2026
    Same journal

    Geographic diversity in top dermatology journal editorial boards.

    The British journal of dermatology·2026
    Same journal

    Molecular heterogeneity in systemic sclerosis skin: insights from single-cell and spatial omics, and implications for disease stratification and cutaneous assessment.

    The British journal of dermatology·2026
    See all related articles

    Area of Science:

    • Dermatology
    • Gastroenterology
    • Pathology

    Background:

    • Malignant atrophic papulosis (MAP), described in 1942, is a syndrome characterized by a distinctive cutaneous eruption.
    • While the skin manifestation is constant, MAP can affect various visceral organs, including the small intestine and nervous system.

    Purpose of the Study:

    • To describe the clinical presentation, histological findings, and potential therapeutic approaches for malignant atrophic papulosis.
    • To highlight the diagnostic challenges and serious prognosis associated with MAP.

    Main Methods:

    • Clinical case description and analysis.
    • Histopathological examination of skin lesions, focusing on vasculitis and thrombosis.
    • Review of existing literature on MAP etiology and treatment.

    Related Experiment Videos

    Main Results:

    • The cutaneous eruption of MAP, though seemingly benign, is associated with severe gastrointestinal and neurological complications.
    • Histology reveals dermal necrosis due to vasculitis with thrombosis in small vessels, lacking significant inflammatory response, differentiating it from other angiitis.
    • The etiology of MAP remains uncertain, with a possible viral link suggested.

    Conclusions:

    • Malignant atrophic papulosis presents a significant diagnostic and therapeutic challenge due to its severe systemic involvement.
    • The characteristic histological features are key to differentiating MAP from other vasculitic conditions.
    • Current treatment options are limited, with heparin showing occasional benefit, underscoring the need for further research.